TNNT1 and chronic kidney disease: Patients with elevated TnT levels had significantly higher rates of comorbidities including hypertension (33 [63.5%] vs 28 [20.7%]), coronary heart disease (17 [32.7%] vs 4 [3.0%]), cardiomyopathy (8 [15.4%] vs 0), diabetes (16 [30.8%] vs 12 [8.9%]), chronic obstructive pulmonary disease (4 [7.7%] vs 0), and chronic kidney disease (1 [0.7%] vs 5 [9.6%]).